Screener
Akebia Therapeutics AKBA Q3 2025 earnings
Reported November 10, 2025 · Before market open
Revenue$58.8MBeat by $10.4M
EPS$0.00Beat by $0.06
Revenue estimate$48.4M
EPS estimate-$0.06
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$46.9M
EPS estimate-$0.03
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Akebia Therapeutics report Q3 2025 earnings?
- Akebia Therapeutics (AKBA) reported Q3 2025 earnings on November 10, 2025 before market open.
- What were Akebia Therapeutics's Q3 2025 revenue and EPS?
- Akebia Therapeutics reported revenue of $58.8M and eps of $0.00 for Q3 2025.
- Did Akebia Therapeutics beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $48.4M by $10.4M. EPS beat the consensus estimate of $-0.06 by $0.06.
- How did Akebia Therapeutics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 57.0% from $37.4M a year earlier.
- Where can I find Akebia Therapeutics's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001517022-25-000045) and the 10-Q periodic report (0001517022-25-000046) directly on SEC EDGAR. The filing index links above go to sec.gov.
